Sunimaps 50mg Capsule is a medication containing Sunitinib as its active ingredient. Sunitinib is a targeted therapy drug, specifically a tyrosine kinase inhibitor. It works by blocking the activity of certain proteins (tyrosine kinases) that are involved in the growth and spread of cancer cells. By inhibiting these proteins, Sunimaps helps to slow down or stop the growth of tumors and can also reduce the formation of new blood vessels that feed the cancer.
Sunimaps 50mg Capsule is indicated for the treatment of certain types of cancer, including advanced renal cell carcinoma (kidney cancer), imatinib-resistant gastrointestinal stromal tumors (GIST), and advanced pancreatic neuroendocrine tumors (pNET). The dosage and duration of treatment are determined by a healthcare professional based on the specific type and stage of cancer being treated, as well as the patient’s overall health and response to the medication.
Common side effects may include fatigue, diarrhea, nausea, vomiting, hair color changes, loss of appetite, and high blood pressure. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Sunimaps 50mg Capsule should be stored at room temperature, away from moisture and heat. It is crucial to follow your doctor’s instructions precisely when taking this medication.
